Moving People

News

/ News / Article

  • Independent

UK records 1,001 more coronavirus deaths





Latest figures from the government have said a further 1,001 people have died within 28 days of testing positive for Covid-19 on Wednesday.

There have also been a further 13,013 more lab-confirmed cases of coronavirus in the UK as of 9am, bringing the total number of cases to 3,985,161.


The official coronavirus death toll in the UK now stands at 114,851.

Government data up to 9 February shows that of the 13,577,851 jabs given in the UK so far, 13,058,298 were first doses - a rise of 411,812 on the previous day.

This means nearly one in four adults in the UK have received a first dose.

Some 519,553 were second doses, an increase of 3,161 on figures released the previous day.

It comes as the World Health Organisation (WHO) recommended the use of the Oxford/AstraZeneca jab in all adults, after several countries opted not to give the jab to people aged over 65.


Dr Alejandro Cravioto, chairman of the WHO's Strategic Advisory Group of Experts on Immunisation, told a press briefing: "In the case of the data coming from clinical trials, we have seen that there was a small participation of people over 65 years of age.


"However, the results of the efficacy estimate for persons up to 65 and older, had a wide confidence interval. And therefore we feel that the response of this group cannot be any different to groups that are of a younger age.


"Since we have identified people over 65 was one of our priority groups in the prioritisation roadmap... looking at the safety and immunogenicity data... we recommend for the vaccine to be used in people 18 years and above, without an upper age limit.

"That means people over 65 years of age should be given the vaccination."

Dr Alejandro Cravioto, chairman of the WHO's Strategic Advisory Group of Experts on Immunisation, told a press briefing: "In the case of the data coming from clinical trials, we have seen that there was a small participation of people over 65 years of age.


"However, the results of the efficacy estimate for persons up to 65 and older, had a wide confidence interval. And therefore we feel that the response of this group cannot be any different to groups that are of a younger age.

"Since we have identified people over 65 was one of our priority groups in the prioritisation roadmap... looking at the safety and immunogenicity data... we recommend for the vaccine to be used in people 18 years and above, without an upper age limit.


"That means people over 65 years of age should be given the vaccination."

0 views
construction-image1.jpg

Subscribe and keep up to date with all the latest news from Oakmark

Subtle Shapes Transparent
WEST AFRICA'S NO.1 ECONOMIC AGENTS

Oakmark Global Vision provides a bespoke business package to established corporate bodies, investors, and entrepreneurs who desire to enter the West & Pan African market. Find out more >

© 2021 Oakmark Global Vision Ltd - All Rights Reserved.

UK Company No. 07634879 / Nigeria Company No. RC 1288232

Regional Office

International Office

1 Kandi Close, Off Aminu Kano

Crescent, Wuse 2, Abuja F.C.T

Nigeria 

+234 -(0)- 929 207 02

+234 (0) 704 497 6500

info@oakmarkglobalvision.com

King Court, 17 School Road

Hall Green, Birmingham

United Kingdom  B28, 8JG

+44 (0) 121 244 1814

+44 (0) 746 625 2505

info@oakmarkglobalvision.com

 Oakmark Global Vision Limited